POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 50 MG SOLUTION FOR INFUSION, 1 PIECE - Turkey License 843787b8dd6727b5032f6cc9f7d26a1e
Access comprehensive regulatory information for POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 50 MG SOLUTION FOR INFUSION, 1 PIECE in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number 843787b8dd6727b5032f6cc9f7d26a1e with license number 2022/336and contains active ingredient Anidulafungin. The license is held by DEVA HOLDฤฐNG A.ล..
This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free Database
Powered by Pure Global AI
21,000+ Products
843787b8dd6727b5032f6cc9f7d26a1e
License Details
Turkey SFDA License: 843787b8dd6727b5032f6cc9f7d26a1e
Product Details
POWDER FOR CONCENTRATE TO BE USED IN THE PREPARATION OF DULAFUX 50 MG SOLUTION FOR INFUSION, 1 PIECE
TR: DULAFUX 50 MG ฤฐNFรZYONLUK รรZELTฤฐ HAZIRLAMADA KULLANILACAK KONSANTRE ฤฐรฤฐN TOZ, 1 ADET
Pharmaceutical Product

